Publication | Closed Access

Epigallocatechin-3-gallate exhibits anti-fibrotic effect by attenuating bleomycin-induced glycoconjugates, lysosomal hydrolases and ultrastructural changes in rat model pulmonary fibrosis

FibrosisLung InflammationMedicineExtracellular MatrixPathologyBleomycin-induced GlycoconjugatesPulmonary PharmacologyPulmonary FibrosisLysosomal HydrolasesPharmacologyCell BiologyUltrastructural ChangesOxidative Stress